中华心律失常学杂志
中華心律失常學雜誌
중화심률실상학잡지
CHINESE JOURNAL OF CARDIAC ARRHYTHMIAS
2012年
3期
180-183
,共4页
梁义秀%宿燕岗%柏瑾%王蔚%秦胜梅%汪菁峰%潘文志%葛均波
樑義秀%宿燕崗%柏瑾%王蔚%秦勝梅%汪菁峰%潘文誌%葛均波
량의수%숙연강%백근%왕위%진성매%왕정봉%반문지%갈균파
心脏性猝死%植入型心律转复除颤器%适应证%一级预防
心髒性猝死%植入型心律轉複除顫器%適應證%一級預防
심장성졸사%식입형심률전복제전기%괄응증%일급예방
Sudden cardiac death%Implantable cardioverter defibrillator%Indication%Primary prevention
目的 了解植入型心律转复除颤器(ICD)植入数量与心脏性猝死(SCD)一级与二级预防患者临床资料特征,为ICD患者筛选提供实践依据.方法 连续入选2006年1月至2011年12月于我院行ICD或心脏再同步治疗除颤器(CRT-D)植入术的患者,收集患者术前资料与患者植入ICD类型,分析历年ICD植入数量与一级、二级预防患者资料的特征与差异.结果 入选214例患者,一级预防108例,二级预防106例.ICD植入数量与一级预防患者比例逐年增加.与二级预防患者相比,一级预防患者术前心功能(NYHA分级)更差(P<0.01),术前左心室射血分数更低[(0.34±0.01)对(0.50±0.16),P<0.01],QRS时限更长[(135.83±35.08)ms对(111.68±34.15)ms,P<0.01],log (NT-proBNP)水平更高[(3.32±0.62)pg/ml对(2.83±0.83) pg/ml,P<0.01],肾小球滤过率更低[(75.15±24.23) ml/min对(90.25±70.30) ml/min,P=0.037];一级预防患者冠状动脉疾病与扩张型心肌病占90%,与二级预防患者疾病组成差异有统计学意义(P<0.01),两组内冠状动脉疾病比例均较低(13.1%与22.6%);二级预防患者主要植入单腔ICD(84.0%),而一级预防患者植入CRT-D比例最高(74.1%),组间植入ICD类型差异有统计学意义(P<0.01).结论 ICD植入数量与一级预防患者比例逐年增加,一级预防患者的识别与植入工作有待改进,特别是心肌梗死后左心室功能不良患者与未符合心脏再同步治疗适应证的慢性心功能不良患者的识别.
目的 瞭解植入型心律轉複除顫器(ICD)植入數量與心髒性猝死(SCD)一級與二級預防患者臨床資料特徵,為ICD患者篩選提供實踐依據.方法 連續入選2006年1月至2011年12月于我院行ICD或心髒再同步治療除顫器(CRT-D)植入術的患者,收集患者術前資料與患者植入ICD類型,分析歷年ICD植入數量與一級、二級預防患者資料的特徵與差異.結果 入選214例患者,一級預防108例,二級預防106例.ICD植入數量與一級預防患者比例逐年增加.與二級預防患者相比,一級預防患者術前心功能(NYHA分級)更差(P<0.01),術前左心室射血分數更低[(0.34±0.01)對(0.50±0.16),P<0.01],QRS時限更長[(135.83±35.08)ms對(111.68±34.15)ms,P<0.01],log (NT-proBNP)水平更高[(3.32±0.62)pg/ml對(2.83±0.83) pg/ml,P<0.01],腎小毬濾過率更低[(75.15±24.23) ml/min對(90.25±70.30) ml/min,P=0.037];一級預防患者冠狀動脈疾病與擴張型心肌病佔90%,與二級預防患者疾病組成差異有統計學意義(P<0.01),兩組內冠狀動脈疾病比例均較低(13.1%與22.6%);二級預防患者主要植入單腔ICD(84.0%),而一級預防患者植入CRT-D比例最高(74.1%),組間植入ICD類型差異有統計學意義(P<0.01).結論 ICD植入數量與一級預防患者比例逐年增加,一級預防患者的識彆與植入工作有待改進,特彆是心肌梗死後左心室功能不良患者與未符閤心髒再同步治療適應證的慢性心功能不良患者的識彆.
목적 료해식입형심률전복제전기(ICD)식입수량여심장성졸사(SCD)일급여이급예방환자림상자료특정,위ICD환자사선제공실천의거.방법 련속입선2006년1월지2011년12월우아원행ICD혹심장재동보치료제전기(CRT-D)식입술적환자,수집환자술전자료여환자식입ICD류형,분석력년ICD식입수량여일급、이급예방환자자료적특정여차이.결과 입선214례환자,일급예방108례,이급예방106례.ICD식입수량여일급예방환자비례축년증가.여이급예방환자상비,일급예방환자술전심공능(NYHA분급)경차(P<0.01),술전좌심실사혈분수경저[(0.34±0.01)대(0.50±0.16),P<0.01],QRS시한경장[(135.83±35.08)ms대(111.68±34.15)ms,P<0.01],log (NT-proBNP)수평경고[(3.32±0.62)pg/ml대(2.83±0.83) pg/ml,P<0.01],신소구려과솔경저[(75.15±24.23) ml/min대(90.25±70.30) ml/min,P=0.037];일급예방환자관상동맥질병여확장형심기병점90%,여이급예방환자질병조성차이유통계학의의(P<0.01),량조내관상동맥질병비례균교저(13.1%여22.6%);이급예방환자주요식입단강ICD(84.0%),이일급예방환자식입CRT-D비례최고(74.1%),조간식입ICD류형차이유통계학의의(P<0.01).결론 ICD식입수량여일급예방환자비례축년증가,일급예방환자적식별여식입공작유대개진,특별시심기경사후좌심실공능불량환자여미부합심장재동보치료괄응증적만성심공능불량환자적식별.
Objective To study the clinical characteristics of patients undergoing implanted cardioverter defibrillator (ICD) implantation for primary prevention (PP) and secondary prevention (SP) of sudden cardiac death (SCD).Methods Patients undergoing implantation of ICD or cardiac resynchronization therapy with defibrillator function ( CRT-D ) during 2006 to 2011 were consecutively recruited,of whom clinical data were collected.Change in the quantity of total implantations as well as proportion of PP implantations through years were calculated,and clinical characteristics of patients were compared between PP and SP groups.Results A total of 214 patients were enrolled,including 108 for PP and 106 for SP.Both the total number of implantations and proportion of SP implantations increased over the years.Patients of PP suffer worse NYHA class ( P<0.01 ),lower left ventricular ejection fraction[ (0.34±0.10) vs.(0.50±0.16),P<0.01 ],more widened QRSduration [ ( 135.83±35.08 ) ms vs.( 111.68 ±34.15 ) ms,P<0.01 ],higher level of log (NT-proBNP) [ (3.32±0.62 ) pg/ml vs.(2.83 ±0.83 ) pg/ml,P<0.01 ],and lower glomerular filtration rate [ ( 75.15±24.23 ) ml/min vs.( 90.25 ± 70.30 ) ml/min,P =0.037 ].Constitution of primary heart diseases was significantly different between PP as SP groups( P<0.01 ),with low proportion of coronary heart disease in both groups( 13.1% and 22.6% ).Most patients of SP received single-chamber ICD(84.0% ),while most PP patients received CRT-D (74.1% ),given significant difference between groups ( P<0.01 ).Conclusion With the increase in quantity of total implantations and proportion of PP implantations,PP patient screening deserves more attention,especially those of left ventricular dysfunction after myocardial infarction and without indication for cardiac resynchronization therapy.